Barclays Initiates Alkermes With Overweight

Analysts at Barclays initiated coverage on

with a Overweight rating. The target price for Alkermes is set to $74. Alkermes shares have gained 37.36 percent over the past 52 weeks, while the S&P 500 index has surged 12.33 percent in the same period. Alkermes' shares rose 0.02 percent to $62.11 in after-hours trading.